Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment
Open Access
- 1 January 2014
- journal article
- Published by Medknow in Industrial Psychiatry Journal
- Vol. 23 (2) , 163-5
Abstract
Catatonia is a syndrome, comprised of symptoms such as motor immobility, excessive motor activity, extreme negativism, and stereotyped movements. Neuroleptic is able to induce catatonia like symptoms, that is, the neuroleptic malignant syndrome (NMS). In NMS, patients typically show symptoms such as an altered mental state, muscle rigidity, tremor, tachycardia, hyperpyrexia, leukocytosis, and elevated serum creatine phosphorous kinase. Several researchers have reported studies on catatonia and the association between catatonia and NMS, but none were from this part of the eastern India. In our case, we observed overlapping symptoms of catatonia and NMS; we wish to present a case of this diagnostic dilemma in a patient with catatonia, where a detailed history, investigation, and symptom management added as a great contribution to the patient's rapid improvement.Keywords
This publication has 14 references indexed in Scilit:
- Olanzapine induced neuroleptic malignant syndromeIndian Journal of Pharmacology, 2013
- Is There A Common Neuronal Basis for Autism and Catatonia?2006
- Zotepine‐Induced Catatonia as a Precursor in the Progression to Neuroleptic Malignant SyndromePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Neuroleptic malignant syndromeBritish Journal of Anaesthesia, 2000
- Proposed research diagnostic criteria for neuroleptic malignant syndromeInternational Journal of Neuropsychopharmacology, 1999
- Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Neuroleptic malignant syndrome and catatonia: One entity or two?Biological Psychiatry, 1996
- The role of creatine kinase in the diagnosis of Neuroleptic Malignant SyndromePsychological Medicine, 1993
- Neuroleptic Toxicity Syndromes: A Clinical SpectrumAustralian & New Zealand Journal of Psychiatry, 1991
- Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology.Journal of Neurology, Neurosurgery & Psychiatry, 1989